β2-adrenoceptor agonist fenoterol enhances functional repair of regenerating rat skeletal muscle after injury

Journal of Applied Physiology

Volumn 96, Issue 4, 2004, Pages 1385-1392

  Beitzel, Felice ^a   Gregorevic, Paul ^a   Ryall, James G ^a   Plant, David R ^a   Sillence, Martin N ^b   Lynch, Gordon S ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b CHARLES STURT UNIVERSITY   (Australia)

Author keywords

2 agonist; Bupivacaine; Muscle function; Muscle regeneration

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; BUPIVACAINE; FENOTEROL; RADIOLIGAND; BETA ADRENERGIC RECEPTOR; BETA ADRENERGIC RECEPTOR STIMULATING AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; EXTENSOR DIGITORUM LONGUS MUSCLE; HINDLIMB; LIGAND BINDING; MALE; MUSCLE ATROPHY; MUSCLE CONTRACTION; MUSCLE FUNCTION; MUSCLE HYPERTROPHY; MUSCLE INJURY; MUSCLE ISOMETRIC CONTRACTION; MUSCLE MASS; MUSCLE REGENERATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; RAT; RECEPTOR DENSITY; SKELETAL MUSCLE; ANIMAL; CHEMICALLY INDUCED DISORDER; CONVALESCENCE; DRUG EFFECT; INJURY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; REGENERATION; SPRAGUE DAWLEY RAT; TIME; WOUND HEALING;

ADRENERGIC BETA-AGONISTS; ANIMALS; BUPIVACAINE; FENOTEROL; HINDLIMB; ISOMETRIC CONTRACTION; MALE; MUSCLE, SKELETAL; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, ADRENERGIC, BETA; RECOVERY OF FUNCTION; REGENERATION; TIME FACTORS; WOUND HEALING; WOUNDS AND INJURIES;

EID: 1642286674     PISSN: 87507587     EISSN: None     Source Type: Journal    
DOI: 10.1152/japplphysiol.01081.2003     Document Type: Article

References (46)

1. Auman JT, Seidler FJ, Tate CA, and Slotkin TA. Are developing β-adrenoceptors able to desensitize? Acute and chronic effects of β-agonists in neonatal heart and liver. Am J Physiol Regul Integr Comp Physiol 283: R205-R217, 2002.
2. Awede BL, Thissen JP, and Lebacq J. Role of IGF-I and IGFBPs in the changes of mass and phenotype induced in rat soleus muscle by clenbuterol. Am J Physiol Endocrinol Metab 282: E31-E37, 2002.
3. Benoit PW and Belt WD. Destruction and regeneration of skeletal muscle after treatment with a local anaesthetic, bupivacaine (Marcaine). J Anat 107: 547-556, 1970.
4. Bischoff R. Analysis of muscle regeneration using single myofibers in culture. Med Sci Sports Exerc 21: S164-S172, 1989.
5. Bremner P, Siebers R, Crane J, Beasley R, and Burgess C. Partial vs full receptor agonism - a clinical study of inhaled albuterol and fenoterol. Chest 109: 957-962, 1996.
6. Brooks SV and Faulkner JA. Contractile properties of skeletal muscles from young, adult and aged mice. J Physiol 404: 71-82, 1988.
7. Carlson BM and Faulkner JA. The regeneration of noninnervated muscle grafts and marcaine-treated muscles in young and old rats. J Geronotol 51A: B43-B49, 1996.
8. 2-adrenoceptor activation. Am J Physiol Endocrinol Metab 263: E50-E56, 1992.
9. 2-adrenergic agonists on body composition and protein synthesis in the rat. Biosci Rep 4: 83-91, 1984.
10. Garrett RP, Britain KG, Savell JW, Edwards JW, and Smith SB. Body composition of lambs receiving 30 or 60 days of exercise training and (or) fenoterol treatment. Meat Sci 52: 235-246, 1999.
11. Gregorevic P, Williams DA, and Lynch GS. Hyperbaric oxygen increases the contractile function of regenerating rat slow muscles. Med Sci Sports Exerc 34: 630-636, 2002.
12. Hall-Craggs ECB. Rapid degeneration and regeneration of a whole skeletal muscle following treatment with bupivacaine (Marcain). Exp Neurol 43: 349-358, 1974.
13. Hall-Craggs ECB and Seyan HS. Histochemical changes in innervated and denervated skeletal muscle fibres following treatment with bupivacaine (Marcain). Exp Neurol 46: 345-354, 1975.
14. Irwin W, Fontaine E, Agnolucci L, Penzo D, Betto R, Bortolotto S, Reggiani C, Salviati G, and Bernardi P. Bupivacaine myotoxicity is mediated by mitochondria. J Biol Chem 277: 12221-12227, 2002.
15. Ishiura S, Nonaka I, and Sugita H. Biochemical aspects of bupivacaine-induced acute muscle degeneration. J Cell Sci 83: 197-212, 1986.
16. Johnson M. The β-adrenoceptor. Am J Respir Crit Care Med 158: S146-S153, 1998.
17. 2-adrenoceptors in rat skeletal muscles. Biochem Pharmacol 42: 1783-1789, 1991.
18. Lavoie JL, Calderone A, and Béliveau L. A farnesyltransferase inhibitor attenuated β-adrenergic receptor downregulation in rat skeletal muscle. Am J Physiol Regul Integr Comp Physiol 282: R317-R322, 2002.
19. Louboutin JP, Fichter-Gagnepain V, and Noireaud J. External calcium dependence of extensor digitorum longus muscle contractility during bupivacaine-induced regeneration. Muscle Nerve 19: 994-1002, 1996.
20. Lynch GS. Novel therapies for sarcopenia: ameliorating age-related changes in skeletal muscle. Expert Opin Thera Patents 12: 11-27, 2002.
21. Lynch GS. Beta-2 agonists. In: Performance Enhancing Substances in Sport and Exercise, edited by Bahrke MS and Yesalis CE. Champaign IL: Human Kinetics, 2002, p. 47-64.
22. MacLennan PA and Edwards RHT. Effects of clenbuterol and propanolol on muscle mass. Biochem J 264: 573-579, 1989.
23. Marlow SA, McGeachie JK, Tennant M, and Papadimitriou JM. A morphometric technique for the histological quantification of skeletal muscle regeneration. J Anat 189: 151-158, 1996.
24. McElligott MA, Chaung LY, and Barreto A. Effects of a beta-adrenergic agonist on protein turnover in muscle cells in culture. Biochem Pharmacol 38: 2199-2205, 1989.
25. Méndez J and Keys A. Density and composition of mammalian skeletal muscle. Metab Clin Exp 9: 184-199, 1960.
26. Menetrey J, Kasemkijwattana C, Day CS, and Bosch P. Growth factors improve muscle healing in vivo. J Bone Joint Surgery 82: 131-137, 2000.
27. Navegantes LCC, Migliorini RH, and Kettelhut IC, Adrenergic control of protein metabolism in skeletal muscle. Curr Opin Clin Nutr Metab Care 5: 281-286, 2002.
28. Navegantes LCC, Resano NMZ, Migliorini RH, and Kettelhut IC. Role of adrenoceptors and cAMP on the catecholamine-induced inhibition of proteolysis in rat skeletal muscle. Am J Physiol Endocrinol Metab 280: E663-E668, 2001.
29. Nonaka I, Takagi A, Ishiura S, Nakase H, and Sugita H. Pathophysiology of muscle fibre necrosis induced by bupivacaine hydrochloride (Marcaine). Acta Neuropathol (Berl) 60: 167-174, 1983.
30. Parent JB, Tallman JF, Henneberry RC, and Fishman PH. Appearance of β-adrenergic receptors and catecholamine-responsive adenylate cyclase activity during fusion of avian embryonic muscle cells. J Biol Chem 255: 7782-7786, 1980.
31. 2-agonist clenbuterol on biochemical and contractile properties of unloaded soleus fibers of rat. Am J Physiol Cell Physiol 278: C582-C588, 2000.
32. Roberts P and McGeachie JK. The effects of clenbuterol on satellite cell activation and the regeneration of skeletal muscle: an autoradiographic and morphometric study of whole muscle transplants in mice. J Anat 180: 57-65, 1992.
33. 2-agonist isoprenaline. J Anat 184: 309-318, 1994.
34. 3-adrenoceptors. Eur J Pharmacol 348: 53-60, 1998.
35. Rosenblatt JD. A time course study of the isometric contractile properties of rat extensor digitorum longus muscle injected with bupivacaine. Comp Biochem Physiol 101A: 361-367, 1992.
36. Rosenblatt JD and Woods RI. Hypertrophy of rat extensor digitorum longus muscle injected with bupivacaine. A sequential histochemical, immunohistochemical, histological and morphometric study. J Anat 181: 11-27, 1992.
37. 2-Agonist fenoterol has greater effects on contractile function of rat skeletal muscles than clenbuterol. Am J Physiol Regul Integr Comp Physiol 283: R1386-R1394, 2002.
38. 125I] iodocyanopindolol as a specifc probe for beta-adrenergic receptors in differentiating cultured rat skeletal muscle. Cell Differ 12: 321-327, 1983.
39. Segal SS and Faulkner JA. Temperature-dependent physiological stability of rat skeletal muscle in vitro. Am J Physiol Cell Physiol 248: C265-C270, 1985.
40. 2-adrenoceptor density in female rats. Naunyn Schmiedebergs Arch Pharmacol 344: 449-453, 1991.
41. 3-adrenoceptors compared in brown adipose tissue and in skeletal muscle membranes. Br J Pharmacol 109: 1157-1163, 1993.
42. Smith PB and Clark GR. β-Adrenergic receptor-adenylate cyclase alterations during postnatal development of skeletal muscle. Biochim Biophys Acta 633: 274-288, 1980.
43. 2-agonist treatment. J Appl Physiol 92: 941-948, 2002.
44. Takahashi S. Local anaesthetic bupivacaine alters function of sarcoplasmic reticulum and sarcolemmal vesicles from rabbit masseter muscle. Pharmacol Toxicol 75: 119-128, 1994.
45. 2-adrenergic agents salbutamol, terbutalin and NSB 365 (double blind study). Arzneimittelforschung 24: 858-860, 1974.
46. 2+ regulation. Anesthesiology 97: 710-716, 2002.